Velka Krecak-Gveric

Sibenik, Croatia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Serum osmolarity in polycythemia vera and its clinical associations.

Serum osmolarity in polycythemia vera and its clinical associations.

Journal: International journal of laboratory hematology

Published: February 18, 2022

High platelet-to-lymphocyte ratio may differentiate polycythemia vera from secondary polycythemia.

High platelet-to-lymphocyte ratio may differentiate polycythemia vera from secondary polycythemia.

Journal: Wiener klinische Wochenschrift

Published: January 25, 2022

Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as prognostic biomarkers in polycythemia vera.

Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as prognostic biomarkers in polycythemia vera.

Journal: International journal of laboratory hematology

Published: November 12, 2021

Thrombotic risk in secondary polycythemia resembles low-risk polycythemia vera and increases in specific subsets of patients.

Thrombotic risk in secondary polycythemia resembles low-risk polycythemia vera and increases in specific subsets of patients.

Journal: Thrombosis research

Published: October 26, 2021

Hematocrit to hemoglobin ratio as a prognostic marker in polycythemia vera.

Hematocrit to hemoglobin ratio as a prognostic marker in polycythemia vera.

Journal: Wiener klinische Wochenschrift

Published: September 07, 2021

Estimating plasma volume using the Strauss-derived formula may improve prognostication in polycythemia vera.

Estimating plasma volume using the Strauss-derived formula may improve prognostication in polycythemia vera.

Journal: International journal of laboratory hematology

Published: July 28, 2021

Concomitant autoimmune hemolytic anemia and pure red cell aplasia in a patient with chronic lymphocytic leukemia successfully treated with ibrutinib.

Concomitant autoimmune hemolytic anemia and pure red cell aplasia in a patient with chronic lymphocytic leukemia successfully treated with ibrutinib.

Journal: Annals of hematology

Published: May 26, 2021

Autoimmune disorders and the risk of thrombotic events in polycythaemia vera.

Autoimmune disorders and the risk of thrombotic events in polycythaemia vera.

Journal: Leukemia research

Published: May 25, 2021

Low-density lipoprotein (LDL) and the risk of thrombotic events in essential thrombocythemia and polycythemia vera.

Low-density lipoprotein (LDL) and the risk of thrombotic events in essential thrombocythemia and polycythemia vera.

Journal: Annals of hematology

Published: January 11, 2021

Cryptic brain abscess - do not forget hereditary hemorrhagic teleangiectasia!

Cryptic brain abscess - do not forget hereditary hemorrhagic teleangiectasia!

Journal: American journal of hematology

Published: December 28, 2020

Paraneoplastic aortitis in a patient with relapsed multiple myeloma successfully treated with daratumumab, bortezomib and dexamethasone.

Paraneoplastic aortitis in a patient with relapsed multiple myeloma successfully treated with daratumumab, bortezomib and dexamethasone.

Journal: Annals of hematology

Published: November 13, 2020

No Impact of the Increased Number of Cardiovascular Risk Factors on Thrombosis and Survival in Polycythemia Vera.

No Impact of the Increased Number of Cardiovascular Risk Factors on Thrombosis and Survival in Polycythemia Vera.

Journal: Oncology research and treatment

Published: August 21, 2020

Showing 1-12 of 28

Last Updated: 09/26/2026